Please login to the form below
Roche’s Ocrevus shows significant benefit in early-stage MS patients
The data was presented virtually at the American Academy of Neurology annual meeting
Moderna COVID-19 vaccine shortfall could affect UK supply
But deliveries to the EU and Switzerland are not affected by the supply issues
Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses
New post hoc data comes from phase 3 ASCLEPIOS trials
Merck & Co halts development of potential COVID-19 drug MK-7110
Pharma company has abandoned drug due to technical, clinical and regulatory uncertainties
GSK discontinues two feladilimab trials in head and neck cancer
Decision made after recommendation from Independent Data Monitoring Committee
BeiGene, Novartis’s PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC
PD-1 inhibitor improved overall survival compared to chemotherapy medication docetaxel
UK trial evaluating mixed-vaccine regimens includes two more jabs
Results from the first stage of the Com-Cov trial are expected next month
Moderna’s booster vaccine for South African variant demonstrates promising early results
Booster vaccine candidate increase neutralising titers against SARS-CoV-2 variants of concern in preclinical study
Lilly’s RET inhibitor Retevmo shows early promise in new cancer types
Trial included patients with pancreatic, colon, breast and salivary cancer
Adopting a creative IP approach towards biotech clusters
Why big pharma paradigm needs to change
-
A unique ecosystem How life science and healthcare clusters are driving innovation
-
Riding the wave of digital disruptionThe challenges and rewards of meeting consumer expectations
-
Oxford study finds standard asthma medication improves recovery time in COVID-19 patientsEarly treatment with inhaled budesonide could help high-risk patients
-
Opdivo improves survival in oesophageal cancerBMS releases new data from its phase 3 CHECKMATE-648 study
-
Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients
Combination increases complete response rate to 24% compared to chemotherapy alone
-
AZ showcases data for next-generation PARP inhibitor AZD5305Early preclinical data presented at virtual American Association of Cancer Research meeting
-
Roche, Regeneron’s COVID-19 antibody cocktail cuts infection riskREGEN-COV reduced the risk of symptomatic infections by 81% in a phase 3 prevention trial
-
Sanofi pays $160m upfront to acquire Tidal TherapeuticsFrench pharma company's acquisition of pre-clinical stage biotech includes mRNA-based research platform
-
Keytruda shows significant and meaningfully improvement in kidney cancerMerck announces results from its phase 3 KEYNOTE-564 trial
-
Merck & Co appoints Frank Clyburn as president, human healthClyburn joined the company in 2008, most recently serving as chief commercial officer for human health
-
Genmab appoints Tahamtan Ahmadi as chief medical officer, head of experimental medicinesAhmadi joined Genmab in 2017, previously serving as senior vice president, head of oncology
-
Henry Skinner has been appointed as the first CEO of the AMR Action FundThe AMR Action Fund is aiming to strengthen and accelerate antibiotic development
-
Merck’s CEO Kenneth Frazier to retire after ten years in the roleFrazier is handing the reins over to current Merck CFO Robert Davis
-
Research Partnership appoints Hannah Osborn to MedTech director roleOsborne has previously worked at Ipsos and IQVIA
Latest research appointments
COVID-19 Updates and Daily News
Featured jobs
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- GSK discontinues two feladilimab trials in head and neck cancer
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Moderna’s booster vaccine for South African variant demonstrates promising early results
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Oxford study finds standard asthma medication improves recovery time in COVID-19 patients
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
PMHub
Apex.co.uk Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...
Latest intelligence
- Don’t limit diversity to just representation in clinical trials
- What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
- Oh no… not more training
- Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...
- InSite Events™ National Pharma Meeting: A Customer Story
- How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Quick links
Infographics
